MARKET PULSE-Best Buy, Biotelemetry, Safe Bulkers, Solazyme
(For more market insights, including options activity, click on ; for the Day Ahead newsletter link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index futures fell slightly on Thursday. Dow Jones industrial average futures were down 0.11 percent at 16,160, S&P 500 futures were up 0.01 percent at 1,842 and Nasdaq 100 futures were down 0.04 percent at 3,672.25.
** TESLA MOTORS INC, Wednesday close $253, +3.66 pct premarket
The company said on Wednesday it plans to raise $1.6 billion from investors to finance a new battery factory that will help the upstart U.S. automaker reach its goal of producing a lower-priced, mass-market electric car by 2017. Tesla said the new plant, nicknamed the "Gigafactory," would be built in either Nevada, Arizona, New Mexico or Texas.
** SUCAMPO PHARMACEUTICALS INC, Wednesday close $8.39, +24.40 pct after market
The drugmaker reported better-than-expected fourth-quarter results, helped by higher sales of its only approved drug, Amitiza, used for the treatment of chronic idiopathic constipation in adults.
** BIOTELEMETRY INC, Wednesday close $9.85, +16.75 pct after market Continued...